Susquehanna International Group, LLP Axcella Health Inc. Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.16 - $1.1 $5,043 - $34,674	-31,522 Reduced 57.5%	23,300 $7,000
Q3 2022 Nov 14, 2022	BUY	$1.62 - $2.73 $69,843 - $117,698	43,113 Added 368.2%	54,822 $94,000
Q2 2022 Aug 15, 2022	BUY	$1.41 - $2.77 $16,509 - $32,433	11,709 New	11,709 $24,000
Q1 2022 May 16, 2022	SELL	$1.58 - $2.82 $15,831 - $28,256	-10,020 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.06 - $3.61 $20,641 - $36,172	10,020 New	10,020 $21,000

61.6K

Ticker AXLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,500,896
Description
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.